Trexquant Reduces Holdings in Anterix Inc.

Summary

Trexquant Investment LP reduced its stake in Anterix Inc. (NASDAQ: ATEX) by 73.6% during the fourth quarter, now holding 18,814 shares valued at $577,000. Other institutional investors, including Vanguard Group and JPMorgan Chase, also adjusted their holdings. JPMorgan raised Anterix’s target price from $61 to $67, maintaining an ‘overweight’ rating. Anterix’s stock opened at $32.63 with a market capitalization of $606.49 million and a PE ratio of -20.02. 87.67% of stocks are held by institutional investors and hedge funds.Market Beat

Impact Analysis

The reduction in Trexquant’s stake in Anterix Inc. suggests a potential shift in confidence or strategy by this investment firm, which could influence other investors’ perceptions. Despite this reduction, JPMorgan has raised its target price for Anterix, indicating some degree of optimism about the company’s future performance. With a majority of Anterix’s shares held by institutional investors, their actions can significantly impact the stock’s price and volatility. Investors should consider the rationale behind Trexquant’s decision and JPMorgan’s continued optimism. Risks may include volatility due to high institutional ownership, while opportunities might arise from potential positive developments hinted at by JPMorgan’s target price increase.Market Beat